528
Views
15
Downloads
22
Crossref
N/A
WoS
19
Scopus
3
CSCD
Osteoarthritis is characterized by lubrication failure of the articular cartilage and severe inflammation of the joint capsule. Lubricating mesoporous silica nanoparticles (MSNs) have been developed for the treatment of osteoarthritis based on enhanced lubrication and local drug delivery. However, MSNs are difficult to degrade in vivo in a short time, resulting in potential toxic effect due to bioaccumulation. In this study, biodegradable MSNs (bMSNs) were prepared through an oil-water biphase stratification method, and modified with poly(2-methacryloyloxyethyl phosphocholine) (PMPC) to synthesize lubricating drug-loaded nanoparticles (bMSNs-NH2@PMPC) by photopolymerization. The in vitro degradation test demonstrated that the bMSNs and bMSNs-NH2@PMPC almost degraded within 7 days. The tribiological test showed that the lubrication property of the bMSNs-NH2@PMPC was greatly improved, with a reduction of 50% in the friction coefficient (COF) compared with the bMSNs. It was attributed to hydration lubrication mechanism by which a tenacious hydration layer is formed surrounding the zwitterionic headgroups (N+(CH3)3 and PO4- ) in PMPC polyelectrolyte polymer. Additionally, the bMSNs-NH2@PMPC maintained excellent lubrication property under degradation and achieved sustained drug release behavior compared with the bMSNs. In summary, the biodegradable bMSNs-NH2@PMPC developed in this study with the properties of enhanced lubrication and drug delivery may be a promising approach for osteoarthritis therapy.
Osteoarthritis is characterized by lubrication failure of the articular cartilage and severe inflammation of the joint capsule. Lubricating mesoporous silica nanoparticles (MSNs) have been developed for the treatment of osteoarthritis based on enhanced lubrication and local drug delivery. However, MSNs are difficult to degrade in vivo in a short time, resulting in potential toxic effect due to bioaccumulation. In this study, biodegradable MSNs (bMSNs) were prepared through an oil-water biphase stratification method, and modified with poly(2-methacryloyloxyethyl phosphocholine) (PMPC) to synthesize lubricating drug-loaded nanoparticles (bMSNs-NH2@PMPC) by photopolymerization. The in vitro degradation test demonstrated that the bMSNs and bMSNs-NH2@PMPC almost degraded within 7 days. The tribiological test showed that the lubrication property of the bMSNs-NH2@PMPC was greatly improved, with a reduction of 50% in the friction coefficient (COF) compared with the bMSNs. It was attributed to hydration lubrication mechanism by which a tenacious hydration layer is formed surrounding the zwitterionic headgroups (N+(CH3)3 and PO4- ) in PMPC polyelectrolyte polymer. Additionally, the bMSNs-NH2@PMPC maintained excellent lubrication property under degradation and achieved sustained drug release behavior compared with the bMSNs. In summary, the biodegradable bMSNs-NH2@PMPC developed in this study with the properties of enhanced lubrication and drug delivery may be a promising approach for osteoarthritis therapy.
This study was financially supported by National Natural Science Foundation of China (51675296), Tsinghua University-Peking Union Medical College Hospital Initiative Scientific Research Program (20191080593), Tsinghua University Initiative Scientific Research Program (20197050026), Foshan-Tsinghua Innovation Special Fund (FTISF), Research Fund of State Key Laboratory of Tribology, Tsinghua University, China (SKLT2020C11), and Ng Teng Fong Charitable Foundation (202-276-132-13).
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.